Matt Angel, Kyle Garland, Ph.D. and Ian Hay from Factor Bioscience Inc. will be participating at the RNA Leaders USA Congress this week in San Diego. Co-founder and CEO Matt Angel will be giving an oral presentation in the ‘Next Generation RNA: Rewriting RNA’ track alongside colleagues from Tessera Therapeutics and Sail Biomedicines. The Factor Bioscience Inc. team will also be exhibiting! Stop by Booth 31 for some exciting giveaways and to learn more about our next generation approach harnessing #RNA for cell therapy, gene therapy, and RNA therapeutic applications. Presentation details: Presentation Date: September 4th 2:10PM PT Presentation Title: “UltraSlice Gene Editing RNA for Complex Genomic Editing” #RNALeaders #mRNA #GeneEditing #CellReprogramming #CellTherapy #iPSCs #mRNATherapeutics #mRNAVaccines
Factor Bioscience Inc.
Biotechnology Research
Cambridge, Massachusetts 872 followers
Engineering cells. Treating disease. Improving life.
About us
We founded Factor Bioscience to explore new methods for controlling gene expression and cell fate. We innovate in the fields of mRNA, gene editing, cell reprogramming, and nucleic-acid delivery. With over 140 granted patents, Factor Bioscience has unleashed the potential of mRNA to treat disease and improve lives. At Factor, we support a model of unlimited discovery. We believe that breakthroughs arise when scientists are given the freedom and resources to pursue their ideas. At Factor, science is our business. Partner with Factor Bioscience to build the next generation of cell therapies, gene therapies, and RNA therapeutics. For more information, please visit https://factor.bio/
- Website
-
http://factorbio.com
External link for Factor Bioscience Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Privately Held
- Founded
- 2011
- Specialties
- mRNA Reprogramming, Gene Editing, Cell Therapy, Induced Pluripotent Stem Cells (iPS cells), Custom iPS cells, Gene-Edited iPS Cells, Cell Differentiation, GMP Manufacturing of custom cell lines, RNA Therapeutics, Nucleic Acid Delivery, Circular RNA, Biotechnology, Rare Disease, Infectious Disease, Cancer Immunotherapy, Gene Therapy, and Leadership
Locations
-
Primary
Get directions
1035 Cambridge St
Suite 17B
Cambridge, Massachusetts 02141, US
-
Get directions
Cambridge, US
Employees at Factor Bioscience Inc.
Updates
-
Factor Bioscience Inc. successfully defends three U.S. patents covering foundational methods for therapeutic gene editing. The three patents relate to methods for producing gene-edited cells using mRNA and remain in effect. Read the full press release here: https://lnkd.in/eAADJ5DB #patents #USPTO #partnering #factorbio #biotech #mRNA #geneediting #celltherapy
-
This Wednesday Factor Bioscience Inc. Co-Founder and CEO Matt Angel will be presenting at the 4th Annual mRNA-Based Therapeutics Summit in Boston, MA. Joining him during the ‘Translation’ conference session are colleagues from BA Sciences, Capstan Therapeutics, and BioNTech SE. Presentation details: Translation Session: 11:15AM Wednesday July 31st Presentation Title: “Harnessing mRNA Technology to Unlock Cell Engineering Applications Against Solid Tumors” See the program here: https://lnkd.in/gymWPp8H #worldRNA #mRNASummit #mRNA #GeneEditing #CellReprogramming #CellTherapy #iPSCs #mRNATherapeutics #mRNAVaccines
Full Event Guide | mRNA-Based Therapeutics Summit
mrnabased-therapeutics.com
-
Factor Bioscience recently participated at the International Society for Stem Cell Research #ISSCR2024 Annual Meeting in Hamburg Germany. Be sure to check out our website to learn more about our exciting science! https://lnkd.in/gk2e4r7g #ISSCR2024 #mRNA #GeneEditing #CellReprogramming #CellTherapy #iPSCs
-
-
Factor Bioscience Inc. reposted this
Speaker Spotlight Series - Factor Bioscience Inc.🔦 Ahead of the 4th mRNA-Based Therapeutics Summit in just two weeks' time, we caught up with Matt Angel, Chief Executive Officer at Factor Bioscience. Matt will be presenting on "Harnessing mRNA Technology to Unlock Cell Engineering Applications Against Solid Tumors", introducing Factor's proprietary platform applying mRNA to in vivo cell engineering therapeutics, transforming CAR-T cells in vivo to target solid tumors, and expressing gene editing proteins in vivo to turn "cold" tumors into "hot" tumors. Thanks for taking the time to chat to us, Matt! See the full agenda here: https://ter.li/hjpwac #mRNA #RNA #WorldRNA #mRNASummit #mRNATherapeutics #mRNAVaccines
-
Kyle Garland, Ph.D., Raven Hinkel, and Elizabeth Belcher join the Factor Bioscience translational science team. Welcome! Learn more: https://bit.ly/3Uler4l #biotech #cellandgenetherapy #mRNA #geneediting #innovation #translationalscience
-
-
Excited to share: Factor Bioscience has secured a USDOD grant to develop gene-edited cell therapies, starting with the first scalable cell therapy specifically targeting muscle inflammation in Duchenne muscular dystrophy (“DMD”) patients. Learn more: https://prn.to/48w2SeY #biotech #cellandgenetherapy #mRNA #CRISPR #geneediting #DMD #Innovation
-